Sandu Pharmaceuticals Ltd share price logo

Sandu Pharmaceuticals Ltd (524703)

₹60.372.64%

bell
Get free price alerts. Set up your Free investment account to get Live Prices.
Overview
News
Financials
Q1 2024 Results
Technicals

Performance

  • Day's Low

    Day's High

    ₹59.83
    ₹61.98
  • 52 Week's Low

    52 Week's High

    ₹50.1
    ₹85
1 Month Return+ 1.94 %
3 Month Return-2.5 %
1 Year Return+ 10.06 %
Previous Close₹62.01
Open₹60.57
Volume2,760.00
Upper Circuit-
Lower Circuit-
Market Cap₹59.91Cr

Key Statistics

P/E Ratio39.98
PEG Ratio-444.22
Market Cap₹59.91 Cr
P/B Ratio1.66
EPS0

Company Information

Established in 1985, Sandu Pharmaceutical Limited (SPL) manufactures high-quality ayurvedic medicines, with its main production plant located in Chembur, Bombay. The company’s chairman, Bhaskar Sandu, successfully raised Rs 1.77 crore in September 1994 via a public issue of 17,70,000 equity shares to finance the development of their second plant in Goa. Their latest facility, which cost Rs7.28 crore to build, is well-equipped with modern machinery and material-handling systems, all in keeping with high hygienic standards to ensure the quality of their products. As ayurvedic medicines are in high demand in India and abroad due to their minimal side-effects, the Goa plant was inaugurated in 1996-97 and has since sustained steady commercial production.

Share Price: ₹60.37 per share as on 19 Jul, 2024 04:01 PM
Market Capitalisation: ₹59.91Cr as of today
Revenue: ₹15.60Cr as on March 2024 (Q1 24)
Net Profit: ₹0.59Cr as on March 2024 (Q1 24)
Listing date: 01 Jan, 0001
Chairperson Name: K Vinay Kumar
OrganisationSandu Pharmaceuticals Ltd
HeadquartersMumbai
IndustryPharmaceuticals
E-voting on sharesClick here to vote

Insights on Sandu Pharmaceuticals Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Netprofit is up for the last 2 quarters, 0.21 Cr → 0.59 Cr (in ₹), with an average increase of 64.4% per quarter

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 3 years, Sandu Pharma. stock has moved up by 6.2%

  • imgNO EFFECT

    Promoter Holding Unchanged

    img

    Promoters holdings remained unchanged at 42.90% of holdings in Mar 2024 quarter

  • imgNO EFFECT

    Retail Holding Unchanged

    img

    Retail Investor holdings remained unchanged at 57.09% of holdings in Mar 2024 quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Sun Pharmaceuticals Industries Ltd has given 131.9% return, outperforming this stock by 125.7%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Zydus Lifesciences Ltd has given 85.3% return, outperforming this stock by 75.3%

  • imgNEGATIVE IMPACT

    Revenue Fall

    img

    Revenue is down for the last 2 quarters, 17.46 Cr → 15.91 Cr (in ₹), with an average decrease of 8.9% per quarter

Company Financials

Value in ₹ crore
Q'1 24Q/Q Change
Revenue
₹15.60Cr
↓10.50%
Net Income
₹0.59Cr
↑180.95%
Net Profit Margin
3.78%
↑215.00%
2023Y/Y Change
Revenue
₹65.35Cr
-
Net Income
₹1.52Cr
-
Net Profit Margin
2.33%
-
Value in ₹ crore
2023Y/Y Change
Total Assets
₹54.17Cr
↑9.90%
Total Liabilities
₹14.93Cr
↑16.46%
Value in ₹ crore
2023Y/Y Change
Operating Cash Flow
₹0.22Cr
↓76.84%

Shareholding Pattern

InvestorsHoldings %FY Quarter3M change
Promoter Holdings
42.9%
0.00
Foreign Institutions
0%
0.00
Mutual Funds
0%
0.00
Retail Investors
57.09%
0.00
Others
0.01%
0.00

Key Indicators

Sandu Pharmaceuticals Ltd Valuation

Sandu Pharmaceuticals Ltd in the last 5 years

  • Overview

  • Trends

Lowest (30.50x)

June 20, 2022

Today (39.98x)

July 19, 2024

Industry (57.38x)

July 19, 2024

Highest (66.08x)

February 19, 2024

LowHigh

Earnings and Dividends

  • Sandu Pharmaceuticals Ltd Earnings Results

    Sandu Pharmaceuticals Ltd’s net profit jumped 118.52% since last year same period to ₹0.59Cr in the Q4 2023-2024. On a quarterly growth basis, Sandu Pharmaceuticals Ltd has generated 180.95% jump in its net profits since last 3-months.

    Read More about Earnings Results
  • Sandu Pharmaceuticals Ltd Dividends August,2023

    In the quarter ending June 2023, Sandu Pharmaceuticals Ltd has declared dividend of ₹0.75 - translating a dividend yield of 2.48%.

    Read More about Dividends

Technicals Summary

Bearish

Neutral

Bullish

Bearish

Sandu Pharmaceuticals Ltd is currently in a Bearish trading position according to technical analysis indicators.

Frequently Asked Questions

  • Get a PAN card.
  • Open a Demat account.
  • Open a Trading account.
  • Link your Demat account to your Trading account.
  • Fund your Trading account.
  • Place an order to buy Sandu Pharmaceuticals Ltd shares.

Sandu Pharmaceuticals Ltd (524703) share price today is ₹60.37

Sandu Pharmaceuticals Ltd is not listed on NSE

Sandu Pharmaceuticals Ltd is listed on BSE

  • Today’s highest price of Sandu Pharmaceuticals Ltd is ₹61.98.
  • Today’s lowest price of Sandu Pharmaceuticals Ltd is ₹59.83.

PE Ratio of Sandu Pharmaceuticals Ltd is 39.98

PE ratio = Sandu Pharmaceuticals Ltd Market price per share / Sandu Pharmaceuticals Ltd Earnings per share

Today’s traded volume of Sandu Pharmaceuticals Ltd(524703) is 2,760.00.

Today’s market capitalisation of Sandu Pharmaceuticals Ltd(524703) is ₹59.91Cr.

Sandu Pharmaceuticals Ltd(524703Price
52 Week High
₹85
52 Week Low
₹50.1

Sandu Pharmaceuticals Ltd(524703) share price is ₹60.37. It is down -28.98% from its 52 Week High price of ₹85

Sandu Pharmaceuticals Ltd(524703) share price is ₹60.37. It is up 20.50% from its 52 Week Low price of ₹50.1

Sandu Pharmaceuticals Ltd(524703Returns
1 Day Returns
-1.64%
1 Month Returns
1.94%
3 Month Returns
-2.5%
1 Year Returns
10.06%